MDCE is proud to announce a series of global achievements, showcasing our expertise in driving innovation and delivering results in clinical research and regulatory support. From securing FDA Breakthrough Device Designation (BDD) for high-risk devices to successfully completing Post-Market Clinical Follow-up (PMCF) studies, First In Human (FIH) trials, and Multi-Regional Clinical Trials (MRCTs), our projects span across North America, Europe, and Asia-Pacific. These accomplishments reflect MDCE’s commitment to helping clients navigate complex global clinical trial and regulatory pathways, accelerating market access, and improving patient outcomes worldwide. As a trusted partner, MDCE consistently delivers impactful results, supporting medical device innovations on a global scale.

MDCE actively participates in global industry events, showcasing expertise in global clinical trials, global regulatory registrations, and global commercialization. Through keynote speeches, panel discussions, and workshops at international forums, our teams provide cutting-edge insights into clinical trial execution, regulatory pathways, and market strategies. These activities highlight MDCE’s commitment to empowering medical device companies worldwide. By fostering collaboration with global experts, regulators, and industry leaders, MDCE continues to lead the way in navigating the complexities of the international medical device landscape, driving success across North America, Europe, Asia-Pacific, and beyond.